Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data FiEE, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2023
FY2025
Revenue
17.8
29.4
32.3
37.6
48
55.4
50.6
26.1
0.64
6.19
Cost of revenue
12.5
19.2
20.7
26.7
34.4
36.5
38.7
25.6
0.43
0.84
Gross profit
5.37
10.2
11.6
10.9
13.6
18.9
11.9
0.47
0.21
5.35
Research and development
1.52
1.94
1.77
2.24
3.83
6.16
5.82
3.45
0.11
0.05
Selling and marketing
9.15
13.7
15
9.47
0.07
0.42
General and administrative
1.54
2.26
1.65
2.67
5.44
4.89
6.12
4.76
2.06
3.34
Operating expenses
8.25
11.5
11.6
14.1
18.4
20.8
27
17.7
4.44
3.8
Operating income
-2.88
-1.21
0.05
-3.22
-4.82
-1.93
-15
-17.2
-4.24
1.55
Interest expense
0.05
0.1
0.08
0.05
0.05
0.27
0.39
0.39
-0
0.01
Interest income
0
0
0
0.01
0
0.04
0
0
0
Other non-operating income
-0.04
-0.14
-0.1
-0.03
0.99
-0.21
-0.39
-0.38
0
-0.03
Pre-tax income
-2.93
-1.35
-0.05
-3.25
-3.83
-2.13
-15.4
-17.6
-4.24
1.52
Income tax
0.01
0.01
0.03
0.02
0.03
0.06
0.11
0.04
-0.01
0.45
Net income to minority interests
4.22
-0.68
Net income
-2.93
-1.37
-0.07
-3.28
-3.86
-2.2
-15.5
-17.6
-4.22
1.07
EBITDA
-2.34
-0.71
0.42
-2.91
-4.58
-0.97
-14.2
-16.6
-3.95
1.71
EPS, basic
-0.21
-0.09
0.00
-0.18
-0.15
-0.06
-8.38
-8.65
-1.34
0.12
EPS, diluted
-0.21
-0.09
0.00
-0.18
-0.15
-0.09
-8.38
-8.65
-1.34
0.10
Shares, basic (weighted)
13.9
14.9
16
18.1
25.3
39.8
1.86
2.04
3.16
5.62
Shares, diluted (weighted)
13.9
14.9
16
18.1
25.3
39.8
1.86
2.04
3.16
7.08
Balance sheet
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2023
FY2025
Cash and equivalents
0.18
0.23
0.13
1.22
0.77
12.6
0.53
0.71
0.03
3.08
Receivables
2.5
2.23
2.76
4.07
9.2
4.88
2.76
0.7
0
2.11
Inventory
4.93
5.2
7.93
7.44
16.5
33.9
25.4
9.95
Other current assets
0.65
0.58
0.19
0.27
0.4
0.59
0.36
0.04
0.13
0.2
Total current assets
8.26
8.24
11.7
13.1
27.7
52.4
29.6
11.4
0.16
6.61
Property, plant and equipment
0.18
0.16
0.26
0.3
0.46
0.76
0.64
0.43
0.12
0.37
Lease right-of-use assets
0
0.1
0.09
0.24
0.17
0.02
0.03
Goodwill
0
0.06
0.06
Intangible assets
0
0.39
0.26
0.07
0.03
3.53
Other non-current assets
0.59
0.39
0.22
0.35
0.94
0.54
0.51
0.47
0.02
0.23
Total assets
9.02
8.79
12.2
13.9
29.6
54.3
31
12.4
0.31
10.8
Accounts payable
2.5
3.53
4.37
5.02
11.7
12.5
2.84
11.1
0.14
0.51
Accrued liabilities
1.05
1.17
2.23
2.67
7.47
5.28
4.44
1.08
0.29
Deferred revenue
0
0.29
0.63
1.5
Short-term debt
0
2.51
0.03
Total current liabilities
4.86
5.62
8.34
7.79
21.8
23.3
13.8
12.2
0.44
4.18
Long-term debt
0
0.02
Lease liabilities
0
0
0.02
0.1
0.02
Total liabilities
4.86
5.62
8.34
7.79
21.8
23.8
14.6
12.2
0.44
4.18
Total debt
0
2.52
0.03
Paid-in capital
39.9
40.3
41
46.5
64.5
89.3
90.7
92.1
94.9
101
Retained earnings
-35.9
-37.2
-37.3
-40.6
-57.1
-59.3
-74.8
-92.5
-96.7
-95.6
Other comprehensive income
0
-0.01
Shareholders' equity
4.16
3.17
3.88
6.11
7.79
30.5
16.3
0.12
-0.13
6.59
Total equity
4.16
3.17
3.88
6.11
7.79
30.5
16.3
0.12
-0.13
6.59
Total liabilities and equity
9.02
8.79
12.2
13.9
29.6
54.3
31
12.4
0.31
10.8
Shares outstanding
14.7
15.3
16.1
20.9
35.1
45.9
1.88
2.79
3.71
7.93
Cash flow statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2023
FY2025
Net income
-2.93
-1.37
-0.07
-3.28
-3.86
-2.2
-15.5
-17.6
-4.22
1.07
Depreciation and amortization
0.54
0.5
0.37
0.32
0.24
0.96
0.84
0.61
0.28
0.16
Stock-based compensation
0.18
0.2
0.4
0.51
0.44
1
1.17
0.28
0.9
0.12
Deferred income tax
0
0
0
0
0
Change in receivables
-1.43
0.27
-0.53
-1.57
-4.97
4.26
2.22
1.88
1.01
-0.59
Change in inventory
-2.17
-0.48
-2.65
0.47
-8.87
-18
6.69
15.5
0.4
Change in payables
1.84
1.98
1.07
0.66
6.67
0.86
-9.62
8.31
-3.25
0.22
Cash from operations
-4.21
1.33
-1.8
-1.54
-7.09
-14.3
-12.2
4.85
-3.77
3.64
Capital expenditures
-0.06
-0.1
-0.24
-0.17
-0.3
-0.59
-0.28
-0.16
-0.19
Cash from investing
-0.53
-0.25
-0.33
-0.48
-0.58
-0.68
-0.7
-0.38
0.01
-4.87
Debt issued
0
0.58
Stock issued
0
0.18
0.38
0.06
1.17
1.17
0.24
4
Share buybacks
-0.02
-0.02
Cash from financing
3.07
-1.04
2.03
3.26
7.88
26.5
0.82
-4.79
3.08
4.3
Exchange rate effect
-0.01
Net change in cash
-1.67
0.05
-0.1
1.24
0.2
11.5
-12
-0.32
-0.68
3.05
Free cash flow
-4.26
1.23
-2.04
-1.71
-7.4
-14.9
-12.4
4.69
3.45
Interest paid
0.05
0.1
0.08
0.05
0.05
0.27
0.39
0.24
Income taxes paid
0.01
0.01
0.03
0.03
0.03
0.06
0.09
0.04
0.01
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $3.85 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
81.9%
Gross profit / revenue.
Operating margin
43.0%
Operating income / revenue.
EBITDA margin
44.1%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
43.2%
Pre-tax income / revenue.
Net margin
34.7%
Net income / revenue.
FCF margin
32.5%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
27.1%
Cash from operations / revenue.
Effective tax rate
19.6%
Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)
40.3%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
30.2%
Net income / average total assets.
Return on invested capital (ROIC)
77.4%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue
0.6%
Research and development expense / revenue.
Capex / revenue
5.4%
Capital expenditures / revenue.
D&A / revenue
1.2%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
867.9%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
-50.4%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y
-33.6%
Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y
2,483.0%
Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y
-23.4%
Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y
-17.0%
Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value CAGR, 3y
-26.1%
Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y
-3.3%
Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y
3,408.0%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
-29.7%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
-18.3%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
124.1%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
56.3%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
-22.5%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
2.84x
Current assets / current liabilities.
Quick ratio
2.74x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
1.41x
(Cash + short-term investments) / current liabilities.
Free cash flow / net income, when net income is positive.
Capex / operating cash flow
19.8%
Capital expenditures / cash from operations, when that is positive.
Per share
Metric
Value
How it is calculated
EPS, diluted
$0.42
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$1.21
Revenue / diluted weighted shares.
FCF per share
$0.39
Free cash flow / diluted weighted shares.
Operating cash flow per share
$0.33
Cash from operations / diluted weighted shares.
Book value per share
$1.32
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/E
7.22x
Market cap / net income. Only when net income is positive.
P/S
2.51x
Market cap / revenue.
P/B
2.91x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
3.93x
Market cap / tangible book value, when positive.
P/FCF
7.71x
Market cap / free cash flow. Only when free cash flow is positive.
P/OCF
9.24x
Market cap / cash from operations, when positive.
EV/Sales
2.09x
Enterprise value / revenue.
EV/EBIT
4.87x
Enterprise value / operating income, when both are positive.
EV/EBITDA
4.74x
Enterprise value / EBITDA, when both are positive.
EV/FCF
6.43x
Enterprise value / free cash flow, when both are positive.
FCF yield
13.0%
Free cash flow / market cap.
Earnings yield
13.9%
Net income / market cap (the inverse of P/E).
What was FiEE, Inc.'s revenue in fiscal 2025?
FiEE, Inc. reported revenue of $6.2M for fiscal 2025, 867.9% higher than the year before.
Was FiEE, Inc. profitable in fiscal 2025?
Yes. Net income was $1.1M, a net margin of 17.3%.
How much free cash flow did FiEE, Inc. generate in fiscal 2025?
Cash from operations of $3.6M minus capital expenditures of $186.1K left free cash flow of $3.5M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.